Ranid 5+25 mg tabletter Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

ranid 5+25 mg tabletter

stada arzneimittel ag - hydrochlorthiazid, ramipril - tabletter - 5+25 mg

Rosuvastatin "Glenmark" 10 mg filmovertrukne tabletter Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

rosuvastatin "glenmark" 10 mg filmovertrukne tabletter

glenmark arzneimittel gmbh - rosuvastatin calcium - filmovertrukne tabletter - 10 mg

Rosuvastatin "Glenmark" 20 mg filmovertrukne tabletter Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

rosuvastatin "glenmark" 20 mg filmovertrukne tabletter

glenmark arzneimittel gmbh - rosuvastatin calcium - filmovertrukne tabletter - 20 mg

Rosuvastatin "Glenmark" 40 mg filmovertrukne tabletter Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

rosuvastatin "glenmark" 40 mg filmovertrukne tabletter

glenmark arzneimittel gmbh - rosuvastatin calcium - filmovertrukne tabletter - 40 mg

Desmopressin "Newbury" 60 mikrogram resoribletter, sublinguale Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

desmopressin "newbury" 60 mikrogram resoribletter, sublinguale

newbury pharmaceuticals ab - desmopressinacetat - resoribletter, sublinguale - 60 mikrogram

Tivicay Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

tivicay

viiv healthcare bv - dolutegravir - hiv infektioner - antivirale midler til systemisk anvendelse - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Temozolomide Sandoz Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

temozolomide sandoz

sandoz gmbh - temozolomid - glioma; glioblastoma - antineoplastiske midler - til behandling af voksne patienter med nyligt diagnosticeret glioblastom multiforme samtidig med strålebehandling (rt) og derefter som monoterapibehandling. til behandling af børn fra en alder af tre år, unge og voksne patienter med ondartet gliom, såsom glioblastoma multiforme eller anaplastisk astrocytom, der viser recidiv eller progression efter standardbehandling.